650 related articles for article (PubMed ID: 18573148)
41. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
Chen W; Johnson KM; FitzGerald JM; Sadatsafavi M; Leslie WD
Arch Osteoporos; 2018 Oct; 13(1):116. PubMed ID: 30374631
[TBL] [Abstract][Full Text] [Related]
42. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.
Johnell O; Pauwels R; Löfdahl CG; Laitinen LA; Postma DS; Pride NB; Ohlsson SV
Eur Respir J; 2002 Jun; 19(6):1058-63. PubMed ID: 12108857
[TBL] [Abstract][Full Text] [Related]
43. Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
Pérez-Castrillón JL; Vega G; Abad L; Sanz-Cantalapiedra A; Gonzalez Sagredo M; de Luis D; Duenas-Laita A
Ann Nutr Metab; 2008; 53(2):117-21. PubMed ID: 18997459
[TBL] [Abstract][Full Text] [Related]
44. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
[TBL] [Abstract][Full Text] [Related]
45. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?
Mathioudakis AG; Amanetopoulou SG; Gialmanidis IP; Chatzimavridou-Grigoriadou V; Siasos G; Evangelopoulou E; Mathioudakis GA
Respirology; 2013 Jan; 18(1):147-53. PubMed ID: 22985270
[TBL] [Abstract][Full Text] [Related]
46. Influence of age and sex on bone mineral density in dialysis patients.
Grzegorzewska AE; Młot-Michalska M
Adv Perit Dial; 2007; 23():77-81. PubMed ID: 17886608
[TBL] [Abstract][Full Text] [Related]
47. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
48. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.
Hanania NA; Chapman KR; Sturtridge WC; Szalai JP; Kesten S
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of bone mineral density in children with cerebral palsy.
Unay B; Sarici SU; Vurucu S; Inanç N; Akin R; Gökçay E
Turk J Pediatr; 2003; 45(1):11-4. PubMed ID: 12718364
[TBL] [Abstract][Full Text] [Related]
50. [Functional condition of bone tissue in smoking and non-smoking patients with chronic obstructive pulmonary disease].
Ter Arkh; 2005; 77(3):14-8. PubMed ID: 15881092
[TBL] [Abstract][Full Text] [Related]
51. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.
Mazokopakis EE; Starakis IK; Papadomanolaki MG; Batistakis AG; Papadakis JA
Curr Med Res Opin; 2006 Jul; 22(7):1369-73. PubMed ID: 16834835
[TBL] [Abstract][Full Text] [Related]
52. Impact of detraining on bone loss in former collegiate female gymnasts.
Kudlac J; Nichols DL; Sanborn CF; DiMarco NM
Calcif Tissue Int; 2004 Dec; 75(6):482-7. PubMed ID: 15365660
[TBL] [Abstract][Full Text] [Related]
53. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
Kiri VA; Fabbri LM; Davis KJ; Soriano JB
Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
[TBL] [Abstract][Full Text] [Related]
54. Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD.
Van Overveld FJ; Demkow U; Górecka D; De Backer WA; Zieliński J
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():273-82. PubMed ID: 17072055
[TBL] [Abstract][Full Text] [Related]
55. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.
Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD
Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442
[TBL] [Abstract][Full Text] [Related]
56. Bone mineral density in asthmatic patients using low dose inhaled glucocorticosteroids.
El O; Gulbahar S; Ceylan E; Ergor G; Sahin E; Senocak O; Oncel S; Cimrin A
J Investig Allergol Clin Immunol; 2005; 15(1):57-62. PubMed ID: 15864884
[TBL] [Abstract][Full Text] [Related]
57. Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema.
Pedreira CC; King E; Jones G; Moore E; Zacharin M; Varigos G; Cameron FJ
Pediatr Dermatol; 2007; 24(6):613-20. PubMed ID: 18035982
[TBL] [Abstract][Full Text] [Related]
58. Predictors of low bone mineral density in elderly males with chronic obstructive pulmonary disease: the role of body mass index.
Coin A; Sergi G; Marin S; Vianello A; Perissinotto E; Sarti S; Rinaldi G; Mosele M; Inelmen EM; Enzi G; Manzato E
Aging Male; 2010 Jun; 13(2):142-7. PubMed ID: 20429721
[TBL] [Abstract][Full Text] [Related]
59. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
Frediani B; Falsetti P; Bisogno S; Baldi F; Acciai C; Filippou G; Bacarelli MR; Filipponi P; Galeazzi M; Marcolongo R
J Rheumatol; 2004 Jun; 31(6):1083-7. PubMed ID: 15170918
[TBL] [Abstract][Full Text] [Related]
60. Osteoporosis is a toxic effect of long-term etretinate therapy.
DiGiovanna JJ; Sollitto RB; Abangan DL; Steinberg SM; Reynolds JC
Arch Dermatol; 1995 Nov; 131(11):1263-7. PubMed ID: 7503569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
